Mika
Mika (developed by Berlin-based Fosanis) is an AI-powered app-based digital therapeutics platform that supports cancer patients throughout their therapy journey, distributed primarily via a mobile app across Germany with planned UK expansion.
- Company typePrivate
- Founded2017
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Mika does
Mika is an app-based digital therapeutics platform developed by Berlin-based digital health company Fosanis (legal entity). Founded in 2017, the platform is designed to support cancer patients throughout their therapy journey through AI-powered digital interventions. The company positions its core technology as domain-specialized AI applied to oncology, differentiating it from general wellness apps by focusing exclusively on the cancer therapy experience. Mika distributes its product primarily via a direct-to-consumer mobile app, with a parallel healthcare provider integration channel for clinical workflow embedding. The business model is structured around subscription/recurring revenue, though pricing is not publicly disclosed; reimbursement through healthcare systems is a potential monetization pathway aligned with the German DiGA framework. Geographic operations are based in Germany with a publicly stated intention to expand into the UK healthcare market. Mika has raised over €10 million across funding stages, including a May 2022 Series A led by healthcare-specialist investors including Debiopharm Innovation Fund, alongside impact investors Ship2B Ventures and Equity Pitcher, with earlier backing from Ananda Impact Ventures, IBB Ventures, and Plug and Play Insurtech. Strategic priorities articulated in conjunction with funding include international expansion, research center collaborations for clinical validation, and broadening the platform's clinical credibility. The company is co-led by founders Gandolf Finke and Jan Raue as managing directors, with a headcount in the 11-50 range.
Mika firmographics
Firmographics- Name
- Mika
- Legal name
- Fosanis
- Website
- https://mikahealth.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mika (developed by Berlin-based Fosanis) is an AI-powered app-based digital therapeutics platform that supports cancer patients throughout their therapy journey, distributed primarily via a mobile app across Germany with planned UK expansion.
- Ownership category
- akta.pro rank
Mika industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
- akta.pro secondary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where Mika is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Mika business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Digital Therapeutics Platform: Mika operates as an app-based digital therapeutics platform generating revenue through its cancer support technology. As a Series A funded company, the business model appears to be focused on healthcare market expansion with potential reimbursement through healthcare systems or direct patient payments.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Mika product offering
Product offeringCore offering
Mika is an AI-powered mobile digital therapeutics platform that supports cancer patients throughout their therapy journey. Delivered as an app-based product by Fosanis GmbH, it provides personalized digital therapeutic interventions and continuous patient engagement between clinical visits. The offering is focused exclusively on oncology and serves as the company's single unified product.
Product overview
Mika is a single unified app-based digital therapeutics platform developed by Fosanis, a Berlin-based digital health company. The platform provides AI-powered cancer therapy support to patients and serves as the company's core product offering.
Differentiator
Problem solved
Functional benefit
Products and services
- Mika AI-powered app-based digital therapeutics platform that supports cancer patients throughout their therapy journey, delivering personalized digital therapeutic interventions via a mobile app. Built for individual cancer patients and oncology healthcare providers seeking continuous, between-visit support.
Quantifiable outcome
- Over €10 million raised to support international expansion and UK market entry
Companies that use Mika
Customer profileSegments1 record
Ideal customer profiles2 records
Mika technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Mika partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- International Research CentersminorMika plans to foster partnerships with international research centers to support clinical validation and evidence generation. These research partnerships aim to strengthen the platform's clinical credibility and enable data-driven improvements to the AI-powered cancer therapy support.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Mika competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Mika social profiles
Digital presenceMika financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mika leadership team
Management profileNumber of profiles
Profiles2 records
Mika funding detail
Funding detailFunding overview
Funding rounds7 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mika M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mika
What does Mika do?
Mika is an AI-powered mobile digital therapeutics platform that supports cancer patients throughout their therapy journey. Delivered as an app-based product by Fosanis GmbH, it provides personalized digital therapeutic interventions and continuous patient engagement between clinical visits. The offering is focused exclusively on oncology and serves as the company's single unified product.
Is Mika a public or private company?
Mika is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mika founded?
Mika was founded in 2017. It employs 11 to 50 people.
Where is Mika based?
Mika is headquartered in Berlin, Germany, in the Europe region.
How does Mika make money?
One revenue line is on record: digital Therapeutics Platform.
Does Mika have an API?
No public API is recorded for Mika.
What industry is Mika in?
Mika's product category is Digital Therapeutics. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 54151 and its SIC code is 8000.